Multicell Technologies Quick Ratio (MCET) starting from the second quarter 2015 to second quarter 2014, Financial Strength Trends, Rankings, Financial Ratios - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• Quick Ratio
• Working Capital
• LT Debt to Equity
• Debt to Equity
• Leverage Ratio
• Tangible Leverage
• Interest Coverage
• Debt Coverage
• Work. Cap. Per Revenue
Multicell Technologies, Inc.  (MCET)

Multicell Technologies's Quick Ratio

MCET's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth


Multicell Technologies's Cash & cash equivalent grew by 568.78 % in the Q2 2015 sequentially, faster than Current Liabilities, this led to improvement in Multicell Technologies's Quick Ratio to 0.26, above Multicell Technologies, Inc. average Quick Ratio.

Within Biotechnology & Pharmaceuticals industry 77 other companies have achieved higher Quick Ratio than Multicell Technologies in second quarter 2015. While Quick Ratio total ranking has improved so far during the Q2 2015 to 3079, from total ranking in the first quarter 2015 at 3673.

Explain Quick Ratio?
How much Cash & cash equivalents MCET´s has?
What are MCET´s Current Liabilities?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

MCET Quick Ratio (May 31 2015)
Q2		 (Feb 28 2015)
Q1		 (Nov 30 2014)
Q4		 (Aug 31 2014)
Q3		 (May 31 2014)
Q2
Y / Y Current Liabilities Change 11.11 % -1.27 % -16.6 % 3.52 % -0.5 %
Y / Y Cash & cash equivalent Change 110.76 % -77.66 % -23.03 % -26.22 % -18.52 %
Quick Ratio MRQ 0.26 0.04 0.11 0.1 0.14
MCET's Total Ranking # 3079 # 3673 # 3871 # 3190 # 3707
Seq. Current Liabilities Change 11.33 % 20.39 % -20.4 % 4.15 % -1.08 %
Seq. Cash & cash equivalent Change 568.78 % -52.17 % -14.37 % -23.06 % -29.12 %



Quick Ratio second quarter 2015 Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry # 78
Healthcare Sector # 610
Overall Market # 3079


Quick Ratio Statistics
High Average Low
0.36 0.19 0.04
(Feb 29 2012)   (Feb 28 2015)




Financial Statements
Multicell Technologies's Current Liabilities $ 1 Millions Visit MCET's Balance sheet
Multicell Technologies's Cash & cash equivalent $ 0 Millions Visit MCET's Balance sheet
Source of MCET's Sales Visit MCET's Sales by Geography


Cumulative Multicell Technologies's Quick Ratio

MCET's Quick Ratio for the trailling 12 Months

MCET Quick Ratio

 (May 31 2015)
12 Months		 (Feb 28 2015)
12 Months		 (Nov 30 2014)
12 Months		 (Aug 31 2014)
12 Months		 (May 31 2014)
12 Months
Y / Y Current Liabilities TTM Growth -0.78 % -3.67 % -2.64 % 1.74 % -3.15 %
Y / Y Cash & cash equivalent TTM Growth -10.64 % -39.53 % -20.42 % -21.41 % -26.63 %
Quick Ratio TTM 0.14 0.1 0.14 0.14 0.15
Total Ranking TTM # 3874 # 4188 # 4041 # 3756 # 3611
Seq. Current Liabilities TTM Growth 2.87 % -0.33 % -4.08 % 0.88 % -0.12 %
Seq. Cash & cash equivalent TTM Growth 40.37 % -28.54 % -4.88 % -6.34 % -5.01 %

Quick ratio ranking by company, industry and sector >> Back to MCET Financial Strength Comparisons >> Go to Compare MCET Quick Ratio to its Competitors

On the trailing twelve months basis MCET Cash & cash equivalent more than doubled by 110.76 % in Q2 2015 year on year, faster than Current Liabilities, this led to increase in in Multicell Technologies's Quick Ratio to 0.14, Quick Ratio remained below MCET average.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Biotechnology & Pharmaceuticals industry 80 other companies have achieved higher Quick Ratio than Multicell Technologies. While Quick Ratio total ranking has deteriorated compared to the previous twelve months ending in the first quarter 2015 from 2869 to 3743.

Explain Quick Ratio?
How much Cash & cash equivalents MCET´s has?
What are MCET´s Current Liabilities?

TTM Quick Ratio Company Ranking
Within: No.
Within the Biotechnology & Pharmaceuticals Industry # 81
Healthcare Sector # 688
Within the Market # 3079


trailing twelve months Quick Ratio Statistics
High Average Low
0.26 0.16 0.07
(Aug 31 2012)   (Nov 30 2011)




Companies with similar Quick Ratio in the quarter ending May 31 2015, within Biotechnology & Pharmaceuticals Industry Quick RatioMay 31 2015 MRQ Cash & cash equivalentMay 31 2015 MRQ Current Liabilities
Ds Healthcare Group, Inc.  0.37 $ 0.979  Millions$ 2.613  Millions
Moderna Inc   0.34 $ 0.726  Millions$ 2.122  Millions
Multicell Technologies, Inc.  0.26 $ 0.360  Millions$ 1.360  Millions
Zeo Scientifix Inc   0.26 $ 0.127  Millions$ 0.484  Millions
Spotlight Innovation Inc.  0.23 $ 1.026  Millions$ 4.501  Millions
Xtant Medical Holdings Inc   0.20 $ 2.026  Millions$ 10.332  Millions
Cannabis Global Inc.  0.19 $ 0.015  Millions$ 0.080  Millions
Mymetics Corporation  0.06 $ 3.164  Millions$ 48.945  Millions
Premier Biomedical Inc  0.06 $ 0.026  Millions$ 0.420  Millions
Creative Medical Technology Holdings Inc   0.06 $ 0.001  Millions$ 0.011  Millions

Date modified: 2026-09-18T13:11:02+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.